Skip to main content
Article
Brief Report: The Impact of Disease Stage on Early Gaps in ART in the "treatment for All" Era - A Multisite Cohort Study.
Journal of Acquired Immune Deficiency Syndromes (1999)
  • Ingrid T Katz, Harvard Medical School
  • Nicholas Musinguzi, Mbarara University of Science and Technology
  • Kathleen Bell, University of Cape Town Medical School
  • Anna Cross, University of Cape Town Medical School
  • Mwebesa Bosco Bwana, Mbarara University of Science and Technology
  • Gideon Amanyire, Mbarara University of Science and Technology
  • Stephen Asiimwe, Mbarara University of Science and Technology
  • Catherine Orrell, University of Cape Town Medical School,
  • David R Bangsberg, OHSU-PSU School of Public Health
  • Jessica E Haberer, Harvard Medical School
Document Type
Article
Publication Date
12-17-2020
Subjects
  • Real-time monitoring
Disciplines
Abstract

Adoption of "Treat All" policies has increased ART initiation in sub-Saharan Africa; however, unexplained early losses continue to occur. More information is needed to understand why treatment discontinuation continues at this vulnerable stage in care.

Rights

Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc.

DOI
10.1097/QAI.0000000000002605
Persistent Identifier
https://archives.pdx.edu/ds/psu/35346
Citation Information
Katz, I. T., Musinguzi, N., Bell, K., Cross, A., Bwana, M. B., Amanyire, G., Asiimwe, S., Orrell, C., Bangsberg, D. R., & Haberer, J. E. (2021). Brief Report: The Impact of Disease Stage on Early Gaps in ART in the “Treatment for All” Era—A Multisite Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 86(5), 562–567. https://doi.org/10.1097/qai.0000000000002605